Paper Details

  1. Home
  2. Paper Details

Randomized, controlled, evaluator-blinded studies conducted to compare the efficacy and tolerability of 3 over-the-counter acne regimens in subjects with mild or moderate acne.

Author: GreenLawrence, GwazdauskasJennifer, KircikLeon H

Comparative StudyResearch that compares multiple groups/interventions to determine differences/similarities in outcomes/characteristics.
Journal ArticleAn article published in an academic or professional journal that reports original research or scholarly analysis.
Randomized Controlled TrialA clinical trial that randomly assigns participants to treatment and control groups to evaluate the effects of an intervention.
Research Support, Non-U.S. Gov'tResearch funding provided by government agencies outside the United States.

Overview

MaxClarity™, an over-the-counter acne treatment regimen, is as effective as Proactiv® and Murad® in treating mild and moderate acne. MaxClarity was well tolerated and most subjects were satisfied with the treatment.
Paper Details　
Original Abstract of the Article :
BACKGROUND: Acne vulgaris is a common dermatologic disease that most frequently affects adolescents and young adults. Over-the-counter (OTC) acne treatment regimens are increasingly being used by individuals with acne. OBJECTIVES: To compare the efficacy, user satisfaction, and tolerability of the ...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元：
https://pubmed.ncbi.nlm.nih.gov/23377391

データ提供：米国国立医学図書館（NLM）

Comparing Over-the-Counter Acne Regimens: A Head-to-Head Study

[Acne vulgaris] is a common skin condition, particularly affecting [adolescents and young adults]. This research compared the [efficacy and tolerability] of three [over-the-counter (OTC) acne regimens], [MaxClarity™, Proactiv®, and Murad®], in [subjects with mild to moderate acne]. The study involved [two randomized, evaluator-blinded, split-face studies], with [20 subjects] in each. The results showed that [all three regimens] led to [significant reductions in acne lesion counts] and [improvements in acne severity] at [8 weeks]. [MaxClarity™] was [well-tolerated] and [comparable in efficacy] to [Proactiv® and Murad®]. These findings suggest that [MaxClarity™] is a [viable alternative] for [OTC acne treatment] with [similar efficacy and tolerability] to other popular regimens.

A Clearer Picture of OTC Acne Treatment

This research provides a [head-to-head comparison] of [popular OTC acne regimens], offering valuable insights for [consumers seeking effective and safe treatments]. The findings demonstrate that [MaxClarity™] is a [worthy contender] in the [OTC acne market], providing a [comparable alternative] to established brands.

Navigating the Desert of Acne

Imagine a desert traveler, searching for a solution to a persistent skin condition. This research provides a roadmap of [OTC acne treatments], offering a clear comparison of different options. The findings help consumers make informed decisions, navigating the desert of acne with greater confidence.

Dr. Camel's Conclusion

This research reminds us that there are multiple paths to clear skin. Just as a desert traveler can choose the most suitable route to their destination, acne sufferers can choose the OTC regimen that best fits their needs. The study's findings provide a valuable resource for consumers, helping them find a clear path to a healthier complexion.

Date :
  1. Date Completed 2013-08-07
  2. Date Revised 2022-12-07
Further Info :

Pubmed ID

23377391

DOI: Digital Object Identifier

S1545961613P0180X

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.